Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GLG Pharma

GLG Pharma
2009 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
GLG STOCK SYMBOL
1 INVESTMENTS
$0.15 SHARE PRICE (As of Monday Closing)
Description

GLG Pharma SA is a Polish company that operates in the biotechnology industry. It develops, manufactures and sells pharmaceutical products based on STAT3 inhibitors technology. Its flagship project is the development of targeted therapy for TNBC (triple negative breast cancer) and the development of immunochemical based tests for rapid diagnosis of TNBC cancer.

Formerly Known As
M10 SA
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
WAR
Primary Office
  • Ul. Leszczynskiego 4 lok. 25
  • Wroclaw, 50-078
  • Poland

+48 71 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GLG Pharma’s full profile, request a free trial.

GLG Pharma Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.13 - $0.83 $1.33M $0.15 -$0.04 2.28K 8.8M

GLG Pharma Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 4,605 6,271 1,724 2,308
Revenue 0 0 0 5
EBITDA (292) (216) (94) (46)
Net Income (292) (220) (98) (47)
Total Assets 4,770 4,578 3,264 3,453
Total Debt 100 37 112 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GLG Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore GLG Pharma‘s full profile, request access.

Request full access to PitchBook

GLG Pharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 09-Aug-2018 00000 0000000 Drug Discovery 0000000 0000000
To view this company’s complete investment and acquisition history, request access »

GLG Pharma Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore GLG Pharma‘s full profile, request access.

Request full access to PitchBook

GLG Pharma Executive Team (4)

Name Title Board
Seat
Contact
Info
Hector Gomez Ph.D Chief Executive Officer & Vice President of the Management Board
Sunanda Singh MD Director of Cancer Immunology
Michael Lovell Ph.D Vice President
John Whalen MD Chief Medical Officer

GLG Pharma Board Members (2)

Name Representing Role Since Contact
Info
000000 00000 00.0 GLG Pharma Chief Executive Officer & Vice President of the Management Board 000 0000
0000000 0000000 GLG Pharma President of the Management Board 000 0000